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Enterococci are Gram-positive bacteria that are found in plants, soil and as commensals
of the gastrointestinal tract of humans, mammals, and insects. Despite their commensal
nature, they have also become globally important nosocomial pathogens. Within the
genus Enterococcus, Enterococcus faecium, and Enterococcus faecalis are clinically
most relevant. In this review, we will discuss how E. faecium and E. faecalis have
evolved to become a globally disseminated nosocomial pathogen. E. faecium has
a defined sub-population that is associated with hospitalized patients and is rarely
encountered in community settings. These hospital-associated clones are characterized
by the acquisition of adaptive genetic elements, including genes involved in metabolism,
biofilm formation, and antibiotic resistance. In contrast to E. faecium, clones of E. faecalis
isolated from hospitalized patients, including strains causing clinical infections, are not
exclusively found in hospitals but are also present in healthy individuals and animals.
This observation suggests that the division between commensals and hospital-adapted
lineages is less clear for E. faecalis than for E. faecium. In addition, genes that
are reported to be associated with virulence of E. faecalis are often not unique to
clinical isolates, but are also found in strains that originate from commensal niches.
As a reflection of more ancient association of E. faecalis with different hosts, these
determinants Thus, they may not represent genuine virulence genes but may act as
host-adaptive functions that are useful in a variety of intestinal environments. The scope
of the review is to summarize recent trends in the emergence of antibiotic resistance
and explore recent developments in the molecular epidemiology, population structure
and mechanisms of adaptation of E. faecium and E. faecalis.
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INTRODUCTION
Enterococci are low-GC Gram-positive ovococci that can form pairs and chains
of diverse lengths. Bacteria from the genus Enterococcus are facultative anaerobic
and grow optimally at 35◦C, but can tolerate temperatures ranging from 10◦C to
45◦C (Byappanahalli et al., 2012). The genus comprises 54 species (Parte, 2014),
which are ubiquitously present in nature but the gastrointestinal tract (GIT)
Frontiers in Microbiology | www.frontiersin.org 1 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 2
Guzman Prieto et al. High-risk Enterococcal Clones
of animals, including mammals, reptiles, birds (Mundt, 1963a)
and insects (Martin and Mundt, 1972), is thought to be the largest
reservoir of enterococci (Gilmore et al., 2013).
In humans, enterococci are common commensals of the GIT.
In addition, enterococci have become ever more prominent
as a causative agent of nosocomial infections since the 1970s
(Arias and Murray, 2012). Two species, Enterococcus faecalis
and Enterococcus faecium, cause the vast majority of hospital-
acquired enterococcal infections in humans (Agudelo Higuita
and Huycke, 2014). Of these two, E. faecium has rapidly
acquired resistance to several classes of antibiotics. First, in
the 1970s and 1980s, E. faecium gained high-level resistance
to ampicillin (Grayson et al., 1991; Galloway-Peña et al., 2009)
and since the 1980s it acquired resistance to aminoglycosides,
fluoroquinolones, and glycopeptides, particularly vancomycin
(Leclercq et al., 1988; Uttley et al., 1988; National Nosocomial
Infections Surveillance System, 2004). E. faecalis has also acquired
resistance to aminoglycosides, but resistance to ampicillin and
vancomycin is much rarer than in E. faecium (Edelsberg et al.,
2014). Worryingly, resistance to antibiotics that are used to
treat vancomycin resistant enterococci (VRE), like linezolid,
tigecycline, and daptomycin, has already been reported (Aksoy
and Unal, 2008; Montero et al., 2008; Scheetz et al., 2008; Niebel
et al., 2015).
The intrinsic resistance of enterococci to some antibiotics,
including aminoglycosides, and the ability to acquire and
disseminate antibiotic resistance determinants, like those
involved in vancomycin resistance, only partly explain the
recent emergence of these organisms as nosocomial pathogens.
In addition, the plasticity of the enterococcal genomes allow
enterococci to rapidly respond and adapt to selective constraints
by acquiring genetic determinants that increase their ability
to colonize or infect the host (Hendrickx et al., 2009; Palmer
et al., 2012; Lebreton et al., 2013; Van Tyne and Gilmore, 2014).
Other host or environmental factors, most notably exposure
to antimicrobial agents, may favor an increase in colonization
density of enterococci in the GIT of hospitalized patients
(Donskey et al., 2000; Ubeda et al., 2010; Ruiz-Garbajosa et al.,
2012). Antibiotic therapy that leads to the depletion of Gram-
negatives, can reduce production of the antimicrobial peptide
REGIIIγ by Paneth cells, and this may promote the outgrowth of
VRE (Brandl et al., 2008).
Patients undergoing transplants or with underlying diseases,
such as diabetes or renal failure, and patients with long-term
catheter usage, are at higher risk of developing infections
caused by multi-drug resistant (MDR) enterococci (Arias
and Murray, 2012). High-density colonization of the patient
GIT facilitates the transmission of MDR enterococci among
hospital ward through fecal contamination (Arias and Murray,
2012). Therefore epidemiological surveillance and outbreak
investigations, together with infection control polices and
interventions, such as the use of protective barriers and proper
disinfection, are key for infection control of these organisms
in the nosocomial environment (Sydnor and Perl, 2011). High-
level enterococcal GIT colonization can also lead to urinary
tract infections (UTI) (De Vecchi et al., 2013; Neelakanta
et al., 2015), which may progress to bloodstream infections or
endocarditis (Patterson et al., 1995; Fernández-Guerrero et al.,
2002). Enterococci from high-density intestinal populations may
also directly translocate from the GIT into the bloodstream
(Kamboj et al., 2014).
Enterococci have become one of the most common causes
of health care-associated infections with E. faecalis causing
approximately 60% of infections and E. faecium the remainder
(de Kraker et al., 2013; Sievert et al., 2013). This review will
focus on E. faecalis and E. faecium as both species have emerged
as important nosocomial pathogens over the last 30 years
and represent a major hub for the dissemination of antibiotic
resistance genes.
EMERGENCE OF ANTIBIOTIC
RESISTANCE IN ENTEROCOCCI
Enterococcus faecalis and E. faecium exhibit intrinsic resistance
to a broad range of antibiotics. Below we briefly describe the
mechanisms that cause resistance to the classes of antibiotics that
are currently used in the treatment of enterococcal infections.
Compared to other low-GC Gram-positive cocci, enterococci
exhibit decreased susceptibility to β-lactam antibiotics.
The β-lactams act through the inactivation of penicillin-
binding proteins (PBPs), thereby interfering with synthesis of
peptidoglycan. All enterococci display decreased susceptibility
to β-lactam antibiotics due to the expression of PBPs with an
intrinsic low affinity for this class of antibiotics. Resistance to
β-lactams, most notably to ampicillin, is currently far more
widespread in E. faecium than in E. faecalis (Cattoir and Giard,
2014). The most important determinants for β-lactam resistance
in E. faecium are mutations in the genes encoding the PBP5
(Zorzi et al., 1996; Rice et al., 2001; Zhang et al., 2012). There
are clear indications that E. faecium progressed toward high-
level ampicillin resistance in the 1970s and 1980s through the
acquisition of specific mutations in the pbp5 gene (Grayson et al.,
1991; Galloway-Peña et al., 2009, 2011). It is of importance to
note that these chromosomally encoded PBPs can be transferable
(Dahl et al., 2000; Hanrahan et al., 2000; Rice et al., 2005), which
indicates that dissemination of high-level ampicillin resistance
can be the result of both clonal spread of strains with mutated
pbp5 genes and horizontal gene transfer. In addition to mutations
in pbp5, production of β-lactamase has been described in both
E. faecalis and E. faecium (Tomayko et al., 1996; Sarti et al., 2012).
In general, the expression level of beta-lactamase in these species
is low and impact on ampicillin susceptibility marginal.
Another group of antibiotics to which E. faecium and
E. faecalis exhibit moderate intrinsic and high-level acquired
resistance are the aminoglycosides. In E. faecalis, intrinsic
resistance is thought to be caused by the inability of the antibiotic
to enter the cytoplasm and inhibit ribosomal protein synthesis
(Aslangul et al., 2006). In E. faecium, two chromosomally
encoded genes, a 6′-N-aminoglycoside acetyltransferase (aac(6′)-
Ii) (Costa et al., 1993) and an rRNA methyltransferase
(efmM) (Galimand et al., 2011), have been associated with
intrinsic resistance to tobramycin and kanamycin. In addition
to intrinsic resistance to aminoglycosides, the therapeutic
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success of these antibiotics is critically compromised by high-
level resistance, due to the gain of aminoglycoside modifying
enzymes, such as phosphotransferases, acetyltransferases, and
nucleotidyltransferases by E. faecium and E. faecalis (Chow, 2000;
Miller et al., 2014).
The assessment of enterococci, particularly E. faecium, as
important agents of MDR nosocomial infections was definitively
established when they acquired resistance to vancomycin.
While vancomycin-resistant enterococci were virtually non-
existent in hospitals in the USA before 1990, nowadays
87% of E. faecium strains from nosocomial infections are
vancomycin-resistant, while this is only 14% for E. faecalis
(Edelsberg et al., 2014). Vancomycin is a glycopeptide antibiotic,
which prevents cross-linking of peptidoglycan by binding to
the D-alanine-D-alanine (D-Ala-D-Ala) moiety of the peptide
chains that crosslink peptidoglycans. The mechanisms by
which enterococci become resistant to vancomycin have been
extensively reviewed elsewhere (Courvalin, 2006). In short,
enterococci become resistant to vancomycin when the terminal
amino acids of peptidoglycan precursors are altered from D-Ala-
D-Ala to D-Ala-D-lactate (D-Ala-D-Lac) or to D-Ala-D-Serine
(D-Ala-D-Ser), leading to high-level and low-level resistance to
vancomycin, respectively. Nine gene clusters are currently known
to be involved in vancomycin resistance in enterococci. These
vancomycin resistance gene clusters are vanA, vanB, vanD, and
vanM, causing vancomycin resistance through the formation of
D-Ala-D-Lac, and vanC, vanE, vanG, vanL, and vanN which
catalyze the formation of D-Ala-D-Ser (Courvalin, 2006; Boyd
et al., 2008; Xu et al., 2010; Lebreton et al., 2011). The most
frequently found, and thus clinically most relevant, vancomycin
resistance determinants are vanA and vanB, which are both part
of larger gene clusters, which encode a two-component regulatory
system and enzymes involved in the recycling of D-Ala-D-Ala
peptidoglycan precursors to D-Ala-D-Lac. Both vanA and vanB
are located on transposons that contribute to the dissemination
of vancomycin resistance among enterococci (Courvalin, 2006).
Recently, vanM was found to be the most important vancomycin-
resistance determinant among different E. faecium lineages in
hospitals in Shanghai, China (Chen et al., 2015). Differences in
the sequence diversity and prevalence of each van operon could
be due to the different ecological origins of the van clusters. While
vanA seems to have originated from soil organisms, vanB, vanG,
and vanD have been reported in gut commensal microbiota
(Guardabassi et al., 2005; Domingo et al., 2007; Howden et al.,
2013).
While vancomycin resistance emerged and spread in
USA hospitals in the 1990s, carriage of vancomycin-resistant
E. faecium (VREF) was rare among hospitalized patients in
Europe. In contrast, VRE carriage among farm animals, and, to a
lesser extent, in healthy humans was higher in Europe than in the
USA (Klare et al., 1995; Devriese et al., 1996; Stobberingh et al.,
1999). The widespread occurrence of VRE among farm animals
was linked to the use of the vancomycin-analog avoparcin as a
growth promoter in Europe (Bager et al., 1997). The presence
of indistinguishable vancomycin resistance transposons in both
animal and human reservoirs provided the first indication that
animal-derived enterococci could be a reservoir of antibiotic
resistance genes that could be transmitted to humans (Arthur
et al., 1993; Jensen et al., 1998; Woodford et al., 1998; Willems
et al., 1999). After the ban on the use of avoparcin in 1997, the
prevalence of VRE in animal husbandry declined in Europe
(Klare et al., 1999; van den Bogaard et al., 2000; Aarestrup et al.,
2001). In several European countries, the prevalence of VRE
among hospitalized patients increased in the 21st century, but
is still lower than the endemic levels reported in US hospitals
(Bourdon et al., 2011; Gastmeier et al., 2014; Pinholt et al., 2015;
Simner et al., 2015). Levels of VRE among hospitalized patients
are also high in Australia, with 37% of E. faecium bacteremia
isolates exhibiting resistance to vancomycin. Interestingly,
vancomycin resistance in Australian E. faecium isolates is almost
exclusively caused by vanB-type transposons, while vanA is the
major vancomycin-resistance determinant in Europe and the
USA (Coombs et al., 2014).
Due to the emergence and rapid spread of VRE, the antibiotics
linezolid, daptomycin and tigecycline are increasingly used for
the treatment of VRE infections.
Linezolid, the first oxazolidinone antibiotic, was introduced
for clinical use in the USA in 2000. It acts on the ribosome
by binding to a universally conserved site on 23S rRNA of the
large 50S subunit of the ribosome (Colca et al., 2003), thereby
inhibiting elongation of the polypeptide chain. The currently
described linezolid resistance mechanisms alter the peptidyl
transferase center of 23S rRNA, by a mutation in the 23S rRNA
gene, with the G2576T mutation being most prominent (Jones
et al., 2008), mutations in the genes encoding ribosomal proteins
L3 and L4 (Chen et al., 2013) or methylation of the adenine
at position 2503, which is catalyzed by the methyltransferase
Cfr. The cfr gene is encoded on various conjugative and non-
conjugative plasmids in enterococci (Diaz et al., 2012; Shen
et al., 2013). Recently, the oxazolidinone resistance gene optrA
has been identified in E. faecalis and E. faecium isolates of
human and animal origin (Cai et al., 2015; Wang et al.,
2015). This gene codes for an ATP-binding cassette transporter,
which contributes to reduced susceptibility for oxazolidinones
(linezolid and tedizolid) and phenicols (chloramphenicol and
florfenicol). The optrA gene was associated with a conjugative
plasmid (Wang et al., 2015). Nevertheless, linezolid resistance is
still rare. In a study using data from 19 US hospitals in the period
2007–2010, linezolid resistance was reported in 1.1 and 1.8% of
E. faecium and E. faecalis isolates, respectively (Edelsberg et al.,
2014).
Daptomycin is a lipopeptide antibiotic that targets the cell
membrane through interactions with phospholipids (Humphries
et al., 2013). The genetic basis for resistance in E. faecalis and
E. faecium was first studied through genome sequencing of pairs
of strains that developed resistance in vitro or in vivo (Arias
et al., 2011; Palmer et al., 2011; Tran et al., 2013a). Additional
genetic and biochemical work has established the role of the
three-component regulatory system LiaFSR in contributing to
daptomycin resistance in enterococci. The LiaFSR system is
conserved in low-GC Gram-positive bacteria and governs the cell
envelope stress response (Jordan et al., 2006). Mutations in the
liaF gene of E. faecalis lead to a redistribution of cardiolipin-rich
microdomains from the division septum to other regions of the
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cytoplasmic membrane, which affects the antimicrobial activity
of daptomycin. In addition, other mutations in phospholipid
biosynthesis genes, most notably in the cardiolipin synthase gene
cls, are required for full expression of daptomycin resistance in
E. faecalis (Davlieva et al., 2013; Tran et al., 2013b). Similar
mechanisms have been associated with daptomycin resistance
in E. faecium (Munita et al., 2012, 2014; Davlieva et al., 2013).
Notably, emergence of daptomycin resistance in E. faecium
during daptomycin therapy is not always linked to mutations in
liaFSR and mutations in cls may already be sufficient (Kelesidis
et al., 2013; Lellek et al., 2015). Daptomycin resistance is
infrequent, but more common in E. faecium than in E. faecalis.
A worldwide study in isolates from hospitalized patients over
the period 2005–2012 showed levels of daptomycin resistance
of 0.18% for E. faecium and 0.02% for E. faecalis (Sader et al.,
2014). However, in certain settings daptomycin resistance may
be considerably more frequent, as illustrated by a study including
4,274 E. faecium and 7,007 E. faecalis isolates from 19 US
hospitals, which found daptomycin resistance among 3.9 and
0.2% of E. faecium and E. faecalis isolates, respectively (Edelsberg
et al., 2014). Similar levels of daptomycin resistance in E. faecium
were recently reported for a German hospital (Lübbert et al.,
2015).
Tigecycline is a semisynthetic derivative of the broad-
spectrum tetracycline antibiotic minocycline, which acts on the
ribosome by inhibiting its association with aminoacyl-tRNAs.
The emergence of resistance during tigecycline therapy was first
observed in E. faecalis (Werner et al., 2008; Cordina et al., 2012)
and has recently been described in E. faecium (Niebel et al.,
2015). In enterococci, resistance to tigecycline can be mediated
through upregulation of tetracycline resistance determinants
tetL (encoding an eﬄux pump) and tetM (providing ribosomal
protection) (Fiedler et al., 2015) and mutations in the ribosomal
protein rpsJ (Beabout et al., 2015; Cattoir et al., 2015; Niebel
et al., 2015). Tigecycline resistance among E. faecium and
E. faecalis is rare at 0.3% for both species (Hoban et al.,
2015) and the antibiotic can still be used successfully to treat
bacteremias caused by MDR enterococci, especially when it is
used in combination with daptomycin (Polidori et al., 2011). The
recovery of enterococcal isolates with decreased susceptibility to
tigecycline in samples of animal origin is of concern, as extensive
use with tetracyclines in the veterinary setting could select for
tigecycline tolerant strains (Freitas et al., 2011).
In addition to the antibiotics described above, the antibiotics
tedizolid, telavancin, dalbavancin, and oritavancin have recently
been approved by the Food and Drug Administration in the USA
for the treatment of skin infections by Gram-positive bacteria
(Crotty et al., 2016). Tedizolid is an oxazolidinone antibiotic
that has improved in vitro activity compared to linezolid.
Enterococcal strains that have acquired linezolid resistance due
to the acquisition of the cfr gene or the G2576T mutation
in the 23S rRNA gene, may still have relatively low MICs
(≤4 µg/ml) for tedizolid (Barber et al., 2016; Silva-Del Toro
et al., 2016). Telavancin, dalbavancin and oritavancin are semi-
synthetic glycopeptides antibiotics that, similar to vancomycin,
affect peptidoglycan stability by binding to the D-Ala-D-Ala
moiety of the peptide chains that crosslink peptidoglycan chains.
Interestingly, oritavancin is also active against vanA- and vanB-
type vancomycin-resistant enterococci, while telavancin and
dalbavancin have limited activity against enterococci carrying
the vanA-type vancomycin resistance transposon but are active
against enterococci with vanB-type vancomycin resistance (Jones
et al., 2013; Karlowsky et al., 2015). Tedizolid, telavancin,
dalbavancin, and oritavancin may be useful as alternatives
to linezolid and vancomycin, but they do not have radically
different modes of action and they may therefore suffer from the
same resistance mechanisms that are threatening the efficacy of
linezolid and vancomycin. Therefore, antibiotics that target other
structures in the enterococcal cell, including teixobactin (Ling
et al., 2015) and the acyldepsipeptides (Brötz-Oesterhelt et al.,
2005), hold considerable promise as novel compounds for the
treatment of infections with MDR enterococci.
MOLECULAR EPIDEMIOLOGY AND
POPULATION STRUCTURE OF
E. faecium AND E. faecalis
E. faecium
As a consequence of the global rise of VREF, a large number
of molecular epidemiological studies have been performed to
obtain insights into the dissemination of VREF clones in
and between hospitals, in farm animals and healthy humans.
However, methods like pulse-field gel electrophoresis (PFGE),
soon proved to be insufficiently reproducible to study genetic
relatedness of isolates (Morrison et al., 1999).
A first insight into the existence of particular ecotypes
in E. faecium, was obtained by using amplified fragment
polymorphism (AFLP) to infer the genetic relatedness of strains
from diverse hosts and environments (Willems et al., 2000). This
study revealed that strains from hospitalized patients grouped in
a specific sub-population that was distinct from groups of strains
that were isolated from humans in the community and farm
animals.
The use of AFLP for global studies showed the limitations of
this technique for comparisons of data obtained from different
laboratories. Therefore an alternative method, termed multi locus
sequence typing (MSLT), was used in follow-up studies. In
MLST, allelic profiles are based on the sequences of fragments
of a number of housekeeping genes (seven in the case of the
E. faecium and E. faecalis MLST schemes) (Homan et al., 2002;
Ruiz-Garbajosa et al., 2006). Compared to AFLP, MLST has the
distinct advantage that data are easily collated and shared through
an on-line database. The first analyses of E. faecium MLST data
were performed with the algorithm eBurst (Feil et al., 2004)
and confirmed a distinct clustering of strains derived from the
hospital environment. This cluster was named clonal complex 17
(CC17) and soon CC17 was found to be disseminated throughout
the world (Willems et al., 2005; Top et al., 2008). The later use
of larger datasets and different algorithms for the analysis of
MLST data (Didelot and Falush, 2007; Francisco et al., 2009),
showed that eBurst can sometimes fail to correctly assign STs
to clonal complexes (CCs), particularly when genetic variation
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in populations is largely driven by recombination rather than
mutations, like is the case in E. faecium and E. faecalis (Turner
et al., 2007).
Bayesian analysis of population structure (BAPS) has
successfully been used to probabilistically infer the population
structure and levels of recombination of several microbial
pathogens (Corander et al., 2012; Thomas et al., 2014).
When applied to E. faecium MLST data, BAPS allowed the
partitioning of 519 STs of 1720 E. faecium isolates into 13
non-overlapping groups. Of these groups, BAPS 3–3 was
significantly associated with isolates from hospitalized patients,
while BAPS 2–1 and 2–4 were significantly associated with
farm animals. This observation again confirmed that there
exists structure in the E. faecium population, with a distinct
subpopulation of isolates that are almost exclusively found in
hospitalized patients (Willems et al., 2012). One of the important
nodes in the previously described hospital-associated CC17,
ST78, and its descendant STs, grouped in BAPS 2–1 together
with farm animal isolates, while two other important CC17
nodes, ST17 and ST18 with their descendant STs, clustered
in another BAPS group (BAPS 3–3). These findings indicate
that nosocomial E. faecium isolates have not evolved from
a single ancestor, like previously postulated, but rather the
cumulative acquisition of adaptive elements in nosocomial
isolates may have occurred multiple times in different genetic
backgrounds. Another conclusion that could be drawn from
Bayesian modeling of MLST data is that hospital isolates
displayed a relative low-level of admixture, despite the high
recombination rates in E. faecium, suggesting that once strains
have adapted to the distinct hospital niche, they become
ecologically isolated (including isolation by dominance) and
recombination with other populations declines (Willems et al.,
2012).
Despite the overt lack of reproducibility, PFGE long remained
the “gold standard” for molecular typing of E. faecium until
the introduction of whole genome sequence (WGS)-based
epidemiology. Howden et al. (2013) published a landmark
study in which they used whole genome sequencing to track
an outbreak of vanB-VREF in a large hospital in Australia.
Interestingly, detailed phylogenomic analysis and precise
mapping of the vanB gene revealed that 18 of the 36 vanB-
VREF had acquired the vanB transposon during the outbreak
period. This indicates that for vanB-VREF, frequent de novo
generation of VREF through horizontal gene transfer may
contribute to the emergence of VREF, in addition to clonal
spread. This study was followed by multiple other studies that
used whole genome sequencing to investigate the molecular
epidemiology of VREF with high resolution and high accuracy
(Reuter et al., 2013; Salipante et al., 2015; Brodrick et al., 2016;
van Hal et al., 2016). Bender et al. (2016) performed whole
genome sequencing of 49 vanB-VREF, primarily of ST192
(39/49), from invasive infections from hospitals all across
Germany and found that spread of the Tn1549-vanB-type
resistance involved exchange of large chromosomal fragments
between vanB-positive and vanB-negative enterococci rather
than independent acquisition events of the vanB transposon
alone.
WGS-based studies also proposed that the E. faecium
population was divided into two species-level subdivisions, based
on phylogenetic analysis and the determination of average
nucleotide identity (ANI) between the two sub-populations.
The sub-populations were termed clade A or hospital-associated
clade, primarily containing isolates from hospitalized patients
and clade B or community-associated clade, mostly containing
isolates from healthy, non-hospitalized individuals (Galloway-
Peña et al., 2012; Palmer et al., 2012). The high level of
diversity between these two clades indicates that the clade A–
B split is ancient and precedes the modern antibiotic era.
Further work provided further evidence for this split and
showed that the population of E. faecium in clade A had
a second split of more recent date (74 ± 30 years), with
clade A1 containing the majority of clinical isolates and clade
A2 mostly comprising animal-derived strains (Lebreton et al.,
2013). WGS also confirmed that E. faecium was subject to
high rates of recombination, leading to changes in MLST
profile in otherwise closely related strains, which invalidates
the use of MLST for tracking transmission events (van Hal
et al., 2016). Another finding of van Hal et al. (2016) was
that other E. faecium strains are the most important donors
of imported DNA fragments. Specifically, strains from clade
B are an important reservoir for donating foreign DNA
to clade A strains (de Been et al., 2013). These findings
indicate that hospital-acquired clade A1 E. faecium strains have
recently emerged from a background of human commensal
and animal isolates. Tree-like network representations of
E. faecium genomic relatedness based on cgMLST data
also revealed the distinct clustering of human commensal,
animal and human clinical strains (Figure 1). Notably,
in this analysis the animal isolates do not group in a
single clade A2 but form multiple distinct clusters that
are located in the network, between the human commensal
and clinical isolates, indicating that clade A2 may not be
monophyletic, as previously postulated (Lebreton et al., 2013).
Interestingly, clade A1 E. faecium strains have lower fitness in
natural environments, where they are out-competed by other
E. faecium clones (Leclercq et al., 2013). Similarly, clade B
strains outcompete clade A strains in an animal model of
gut colonization in the absence of selection by antibiotics
(Montealegre et al., 2015). These data highlight the exquisite
niche specialization to the hospital environment of clade A1
strains, which may come at a fitness cost in non-hospital
environments.
The WGS-based epidemiological studies described above
generated phylogenetic trees based on SNPs, by mapping
sequencing reads to a reference genome. This approach, although
providing high-resolution typing data, complicates comparisons
of data between studies and hampers the construction of
globally accessible databases. This limitation may be overcome
by using a genome-wide gene-by-gene comparison approach,
as in classical MLST, but with an important extension of
the number of analyzed genes from seven to the entire core
genome of the species, i.e., 1423 genes as in the recently
published core genome MLST (cgMLST) scheme of E. faecium
(de Been et al., 2015). The E. faecium cgMLST scheme
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FIGURE 1 | NeighborNet phylogenetic network to visualize the relationships between 196 E. faecium isolates. The distance matrix underlying the network
was built from all pairwise allelic profile comparisons of 1423 loci of the published E. faecium cgMLST scheme (de Been et al., 2015). Allelic profiles were extracted
from SeqSphere. Small colored circles indicate the origin of isolates. E. faecium clades (A1 and B) inferred from the STs and based on Lebreton et al. (2013) are
indicated by large dotted circles. Notably, in this analysis clade A2 isolates do not group in a single clade but form at least four distinct clusters that are located in the
network and are indicated clade A2_1, A2_2, A2_3 and A2_4.
allowed high-resolution tracing of E. faecium outbreaks and
performed equally well as an SNP-based phylogenetic approach,
but has the advantage that data can be collated in an online
database and a standardized nomenclature for clones can be
used.
E. faecalis
Enterococcus faecalis appears to be the most widespread and
abundant species of Enterococcus and can be found in the
intestines of humans, farm, companion, and wild animals and
in the environment (Mundt, 1963a,b; Devriese et al., 1992a,b;
Tannock and Cook, 2002; Ruiz-Garbajosa et al., 2009). Initial
molecular epidemiological studies, using MLST, showed the
existence of CCs, in which isolates originating from different
hosts are contained (Ruiz-Garbajosa et al., 2006; McBride
et al., 2007). While many E. faecalis clones are shared between
hospitalized patients and other reservoirs, some CCs (specifically
CC2, CC9, and CC87) and STs (ST6 and ST16) seemed to
be enriched among isolates from hospitalized patients (Ruiz-
Garbajosa et al., 2006; McBride et al., 2007; Freitas et al., 2009;
Kuch et al., 2012). Similarly, in isolates collected from across
the globe, antibiotic resistance is more prevalent in strains that
belong to CC2, CC8, CC9, CC16, and CC87 (Kawalec et al.,
2007; McBride et al., 2007; Freitas et al., 2009; Kuch et al.,
2012).
Analysis of the extent of congruence between the topologies
of the seven different MLST gene trees revealed that that all
42 pairwise comparisons of the sequences of the MLST loci
were incongruent. This observation suggests that E. faecalis
is a highly recombinogenic species (Ruiz-Garbajosa et al.,
2006). For this reason Tedim et al. (2015) used BAPS to
investigate the E. faecalis population structure based on MLST
data of hospitalized (n = 133) and non-hospitalized individuals
(n = 173) isolated from feces. A hierarchical BAPS clustering
analysis partitioned the E. faecalis population into 5 BAPS
groups. Contrary to what has been described in E. faecium
and to eBURST based analyses of E. faecalis MLST data,
no significant association was found between isolates from
hospitalized patients and particular E. faecalis BAPS groups
(Tedim et al., 2015).
The first comprehensive E. faecalis phylogenomic study
involved 18 E. faecalis genomes representing clinical (n = 10),
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human commensal (n = 3), and animal isolates (n = 3),
and isolates of unknown origin (n = 2) (Palmer et al.,
2012). The analysis revealed that the phylogenetic diversity of
E. faecalis was limited compared to E. faecium, with variations
in the ANI in a narrow range between 97.8 and 99.5%.
There was also no clear structure in the phylogenetic core
gene tree, with no distinct clustering of isolates according to
source. Similarly, clustering of these 18 isolates supplemented
with 3 other published E. faecalis genomes from a clinical
site, human feces and pig based on an ad hoc developed
E. faecalis cgMLST scheme using tree-like network methods
also revealed no distinct clustering of isolates according to
their source (Figure 2). A recent genome-based study of 515
E. faecalis genomes, mainly isolated from clinical settings on
the British Isles, revealed three dominant lineages of hospital-
associated lineages (L1, L2, and L3). Isolates in L1 and L3
originated from both the UK and USA (Raven et al., 2016).
These data clearly indicate independent clonal expansion with
subsequent national dissemination. The data may also point
toward the existence of specific hospital-associated or hospital-
adapted lineages. However, in order to unequivocally infer
hospital-adapted lineages it is essential to correct the data
for clonal outbreaks, by including outbreak clones only once
in the analysis. The fact that only a limited number of STs
(3, 2, and 2 STs in lineage 1, 2, and 3, respectively) were
represented in these three lineages may suggest that these lineages
contain multiple replicates of outbreaks clones. Analyses for
recombination frequencies in the core genome of L1, L2 and
L3 isolates indicated low levels of recombination, which seems
to contrast with previous MLST-based analyses (Ruiz-Garbajosa
et al., 2006; Raven et al., 2016). Possibly, recombination drove
the initial diversification of E. faecalis but contributed less to
the relatively recent evolution of the three dominant E. faecalis
lineages described by Raven and co-workers (Raven et al.,
2016).
ADAPTIVE ELEMENTS IN NOSOCOMIAL
LINEAGES
Enterococci are ubiquitous in nature, where they act as
commensals and opportunistic pathogens. A consequence of
these different lifestyles is that enterococci need to adapt to
different micro-environments, each one exerting strong selective
pressures. A strategy for bacterial species to survive when
confronted with a wide range of selective pressures is to specialize
in particular fitness peaks. E. faecium probably followed such
an evolutionary trajectory, resulting in the emergence of specific
hospital-adapted lineages. Successful hospital-adapted clones in
E. faecium have the ability to exchange mobile genetic elements,
carrying antimicrobial resistance, and virulence determinants,
by horizontal gene transfer (Leavis et al., 2003; Hegstad et al.,
2010; Palmer et al., 2010; van Schaik et al., 2010). The cumulative
acquisition of adaptive elements has been named “genetic
capitalism”, in which the acquisition of a particular adaptive
element by a particular clone enhances its fitness, thereby
increasing the likelihood of acquiring a second adaptive element
which finally can lead to the emergence of high-risk multidrug-
resistant clones (Baquero, 2004). This cumulative acquisition of
adaptive elements by the hospital-associated E. faecium clade A1
strains is reflected by their larger genome sizes (2,843 ± 159
genes; 2.98 ± 0.15 Mbp), compared to the genomes of strains
in clade A2 (2,597 ± 153 genes; 2.75 ± 0.14 Mbp) or clade
B (2,718 ± 120 genes; 2.84 ± 0.1 Mbp) (Lebreton et al.,
2013).
The first adaptive element that was described as being specific
for hospital-associated E. faecium strains was Esp (Willems et al.,
2001), a surface protein with a signal sequence for transport and a
LPxTG-like motif for cell wall anchoring. The E. faecium esp gene
is located on an integrative conjugative element, called ICEEfm1,
and contributes to biofilm formation, and UTIs and endocarditis
in animal models (Leavis et al., 2004; Heikens et al., 2007, 2011;
Leendertse et al., 2009; Sava et al., 2010; van Schaik et al., 2010;
Top et al., 2011).
In addition to Esp, other determinants were found to be
specific or significantly enriched among hospital-associated
isolates. Characteristics of these genes have been previously
discussed (Leavis et al., 2003; Heikens et al., 2008; Hendrickx
et al., 2009, 2013; Zhang et al., 2013; Paganelli et al., 2016).
Comparative genomic analyses of 73 E. faecium strains revealed
major differences in gene content between clinical (clade A1),
animal (clade A2) and non-clinical (clade B) strains, particularly
through gain and loss of gene clusters with predicted roles
in carbohydrate metabolism (Kim and Marco, 2013; Lebreton
et al., 2013). Many of the clade B-specific genes have a predicted
role in the utilization of complex carbohydrates from dietary
sources, which were replaced with genes that were associated
with the utilization of amino sugars (e.g., galactosamine), which
occur on epithelial cell surfaces and in mucin. This metabolic
switch may have contributed to the niche specialization of
E. faecium.
As mentioned above the population structure of E. faecalis
seems to be significantly different from E. faecium as no clearly
defined E. faecalis ecotypes appear to exist. Correspondingly,
previous studies have reported shared antibiotic resistance and
virulence genes, such as the E. faecalis pathogenicity island,
esp, capsule polysaccharide genes, and genes encoding for
gelatinase, aggregation substance, cytolysin, and Ace, among
E. faecalis isolates from a wide variety of different niches
like the hospital, animals, food products and the environment
(Eaton and Gasson, 2001; Creti et al., 2004; McBride et al.,
2007; Freitas et al., 2009; Solheim et al., 2009; La Rosa
et al., 2015). Note that the absence of clearly defined ecotypes
in E. faecalis can be interpreted as a high multiplicity of
closely related fine-grained ecotypes, none of them reaching
predominance.
Comparative genomic analysis of 18 E. faecalis genomes
showed that the accretion of mobile genetic elements in multiple
E. faecalis lineages appears to be a major source of genome
diversity (Palmer et al., 2012). Although antibiotic resistance and
pathogenicity island traits have converged in some E. faecalis
lineages, substantial differences in gene content exist, indicating
that specialization toward specific ecotypes is not apparent in
this species, in contrast to E. faecium. In addition, a hierarchical
Frontiers in Microbiology | www.frontiersin.org 7 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 8
Guzman Prieto et al. High-risk Enterococcal Clones
FIGURE 2 | NeighborNet phylogenetic network to visualize the relationships between 21 E. faecalis isolates. The distance matrix underlying the network
was built from all pairwise allelic profile comparisons of 1298 loci of an ad hoc E. faecalis cgMLST scheme using SeqSphere (http://www.ridom.de/seqsphere/).
Small colored circles indicate the origin of isolates.
clustering based on genome content of 38 E. faecalis genomes
from diverse sources including clinical and non-clinical isolates,
unearthed no evidence of distinct lineages in E. faecalis and no
genes were found to be significantly enriched among clinical
or non-clinical strains (Kim and Marco, 2013). A pangenome
analysis of 168 E. faecalis isolates revealed no genes, or even
homoplastic non-synonymous single nucleotide polymorphisms,
that were ubiquitous in the three dominant lineages of hospital
isolates, while being absent from all other sporadic lineages
(Raven et al., 2016). These observations are all in accordance
with high levels of genetic exchange between ecologically diverse
E. faecalis clones.
In bacteria, mechanisms that preclude the acquisition of
foreign DNA, include the Clustered Regularly Interspaced
Short Palindromic Repeats (CRISPR)-Cas system (Horvath
and Barrangou, 2010) and restriction and anti-restriction
modification (RM-, antiRM-) systems (Clewell et al., 2014).
E. faecalis strains lacking CRISPR-Cas appear to more
readily acquire DNA through horizontal gene transfer and,
consequently have a larger genome size than E. faecalis
strains that carry CRISPR-Cas (Palmer et al., 2010, 2012).
This indicates that the CRISPR-Cas status of E. faecalis
strains may contribute to ecological adaptation. In E. faecium
CRISPR-Cas is only found in a subset of clade B strains, again
highlighting the general lack of barriers to horizontal gene
exchange in this species (Lebreton et al., 2013). Restriction
and anti-restriction systems located on mobile elements
or enterococcal chromosomes can also determine the flow
of adaptive traits among populations of the same and/or
different species (Clewell et al., 2014). Anti-RM systems
include analogs of ArdA (alleviation of restriction of DNA)
that are located on conjugative transposons (CTns) that
are found widely spread in enterococci. ArdA proteins
act against Type I restriction systems (detected in Tn916
and CTn6000) and other genes presumptively involved
in methylation (CTn6000) (Clewell et al., 2014). Recently,
a type IIS restriction-modification (R-M) system SfaNI
was described in E. faecalis (Furmanek-Blaszk and Sektas,
2015).
Other strategies seem to have exerted positive as well as
negative selective pressures on E. faecalis clones. E. faecalis
strain V583 uses phage particles to establish and maintain
dominance of its intestinal niche in the presence of closely
related competing strains (Duerkop et al., 2012). Furthermore,
five of the seven prophages in the same strain (phage01,
phage03, phage04, phage05, and phage07) can be excised
from the bacterial chromosome and four of them produced
infective virions that may promote gene dissemination among
isolates and increase pathogenicity (Matos et al., 2013; La
Rosa et al., 2015). Conversely, Gaca and Gilmore recently
demonstrated how the accretion of mobile genetic elements
in E. faecalis V583, renders it unable to co-exist with native
enterococci in healthy human fecal flora (Gaca and Gilmore,
2016).
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CONCLUSION
The ubiquitous nature of enterococci, the flexibility of their
genomes and the widespread use of antibiotics in human and
veterinary medicine, are important factors that drive the current
emergence of E. faecium and E. faecalis as MDR nosocomial
pathogens.
The population structure of E. faecium is characterized by
a deep phylogenetic split that separates human commensal
isolates (clade B) from farm animal and hospital isolates (clade
A). It is tempting to speculate that the deep phylogenetic
split in E. faecium is driven by anthropogenic influences
since strains from farm animals (clade A2) and clinical
isolates (clade A1), share a common feature as they both
originate from environments where mammalian hosts are
in close contact with each other and usage of antibiotics
is high. The evolutionary trajectory of E. faecium, which
has led to a clear clade structure, suggests that E. faecium
is colonizing rugged fitness landscapes, in which characters
of particular clones in clade A and B impose strong fitness
differences. Under these circumstances, gene exchange between
diverging populations is reduced over large genomic regions,
as a collateral effect of strong divergent selection on genes
involved in local adaptation. This mechanism was named
divergence hitchhiking (DH) (Via, 2012). DH facilitates
the divergence of genes linked to genomic regions that
are most involved in local adaptation, and may explain
the evolution of clones in populations with extensive gene
flow. In E. faecium clade A, DH may have contributed
to the fixation of ecologically important genomic traits,
like antibiotic resistance or genes linked to pathogenicity.
Indeed, using a neutral model incorporating microepidemics
and migration, which mimics a situation where ecological
factors may limit transmission between subpopulations,
showed that E. faecium hospital isolates with extensive
genotype relatedness markedly deviated from this neutral
model compared with other common nosocomial bacteria
like Staphylococcus aureus and Staphylococcus epidermidis,
indicating that these hospital isolates represent a subpopulation
adapted to the hospital environment (Numminen et al.,
2016).
The E. faecalis population analyzed in the studies described
above included human commensal, farm animal and clinical
isolates. It is an open question why this anthropogenic
divergence, as observed in E. faecium, is not seen in E. faecalis.
An explanation for this may reside in differences in population
size of both species. Indeed, E. faecalis seems to be more
widespread and abundant in the intestines of cattle, pigs,
dogs, horses and poultry (Devriese et al., 1987, 1991, 1992a,b,
1994). E. faecalis has also been more frequently isolated from
wild mammals, reptiles, birds, insects, and wild plants than
E. faecium (Mundt, 1963a,b; Martin and Mundt, 1972). Finally,
in healthy humans E. faecalis is also more frequently found
than E. faecium (Tannock and Cook, 2002). Moreover, it
seems that E. faecalis clones are maintained longer in the
gut than E. faecium clones (Ruiz-Garbajosa et al., 2009).
The higher population density of E. faecalis relative to
E. faecium, in combination with its broader host-range,
should provide E. faecalis with more opportunities for genetic
exchange and diversification than E. faecium. High population
densities also assure frequent transmission events, favoring
gene flow among strains. This may act as a unifying force
preventing the evolution of distinct clades in E. faecalis.
Using the same neutral model described above for E. faecium,
showed that the population structure of E. faecalis could
be reflective of the evolutionary dynamics of a generalist
organism which regularly experiences a high level of drift
and gene flow between different host species (Numminen
et al., 2016). Different strategies influence interactions of
E. faecalis with populations of the same or of different species.
A mechanism of substantial genetic exchange in E. faecalis has
been postulated by Manson and co-workers, who described
conjugative transfer of chromosomal fragments driven by
integration of pheromone responsive conjugative plasmids
carrying IS256 insertions and recombination across IS256 copies
in the genome (Manson et al., 2010). The authors demonstrated
that such an event could include transfer and recombination
of up to 857 kb (∼ 25% of the genome) and show that
essentially every chromosomal location can be transferred by
this mechanism. Other strategies may include phages, mobile
genetic elements and the generation of polymicrobial biofilms
(Weigel et al., 2007; La Rosa et al., 2015, 2016; Gaca and Gilmore,
2016).
High-level genetic connectivity of strains between different
niches and hosts might favor dissemination of adaptive elements
(e.g., virulence and resistance genes) that are acquired by
E. faecalis populations in one niche (e.g., animals raised for
food production) and finally end up being selected for in
another environment (e.g., the hospital). In fact, the panmictic
structure of E. faecalis favors its behavior as a collective
evolutionary individual, which has promoted the generalist
lifestyle of E. faecalis. The high level of genetic connectivity
of E. faecalis strains in different niches, in combination with
a relative small genome size, is in accordance with the ‘Black
Queen Hypothesis’. According to this hypothesis collective genes
shared in a highly recombinogenic structure act as “common
goods”, and may favor the loss of genes in a particular niche
in individual strains, provided they are not lost entirely from
the community (Morris et al., 2012). While there is evidence
in favor of this hypothesis, there is still a distinct lack of
studies using WGS to describe the evolution, genetic diversity
and population structure of E. faecalis and these are urgently
needed to validate or falsify the current view of E. faecalis as a
generalist.
In conclusion, E. faecium and E. faecalis are widely distributed
among humans, animals and the environment. The social
behavior of enterococci, which includes the accretion of plasmids,
phages and CTns (Werner et al., 2013; Clewell et al., 2014),
but also the ability to maintain microbial communities (Barnes
et al., 2012; Paganelli et al., 2013), has allowed them to rapidly
acquire antibiotic resistance genes and genetic elements that
increase their ability to colonize and infect patients. E. faecium
and E. faecalis differ in their population structure. E. faecium
has clearly defined sub-populations, one of which contains
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the majority of strains that are currently causing nosocomial
infections. In contrast, E. faecalis is a generalist, with
a highly panmictic population where genes involved in
patient colonization or virulence are widely spread across
niches.
AUTHOR CONTRIBUTIONS
Most of the writing for this manuscript was done by AG, WS,
and RW, with MR contributing analyses for both figures and
TC, FB, and JC contributing concepts and text in sections 3 and
4. All authors have contributed to and revised the manuscript
prior to submission. In our opinion, all authors meet the
requirement of authorship as outlined in the Frontiers author
guidelines.
ACKNOWLEDGMENTS
WS is funded through a NWO-Vidi grant (917.13.357). TC and
FB are supported by grants PI12-01581 and PI15-01307 from
the ISCIII-Ministry of Economy and Competitiveness of Spain
(to TC), S2010/BMD2414 from the Regional Government of
Madrid (to FB) and the CIBERESP Network for Biomedical
Research in Epidemiology and Public Health (Instituto Carlos III,
Spanish Ministry of Science and Innovation, reference number
CB06/02/0053).
REFERENCES
Aarestrup, F. M., Seyfarth, A. M., Emborg, H. D., Pedersen, K., Hendriksen,
R. S., and Bager, F. (2001). Effect of abolishment of the use of antimicrobial
agents for growth promotion on occurrence of antimicrobial resistance in fecal
enterococci from food animals in Denmark. Antimicrob. Agents Chemother. 45,
2054–2059. doi: 10.1128/AAC.45.7.2054-2059.2001
Agudelo Higuita, N. I., and Huycke, M. M. (2014). “Enterococcal disease,
epidemiology, and implications for treatment,” in Enterococci: From
Commensals to Leading Causes of Drug Resistant Infection, eds M. S. Gilmore,
D. B. Clewell, Y. Ike, and N. Shankar (Boston: Massachusetts Eye and Ear
Infirmary). Available at: http://www.ncbi.nlm.nih.gov/books/NBK190429/
[Accessed February 21, 2016].
Aksoy, D. Y., and Unal, S. (2008). New antimicrobial agents for the treatment of
Gram-positive bacterial infections. Clin. Microbiol. Infect. Off. Publ. Eur. Soc.
Clin. Microbiol. Infect. Dis. 14, 411–420. doi: 10.1111/j.1469-0691.2007.01933.x
Arias, C. A., and Murray, B. E. (2012). The rise of the Enterococcus:
beyond vancomycin resistance. Nat. Rev. Microbiol. 10, 266–278. doi:
10.1038/nrmicro2761
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., et al.
(2011). Genetic basis for in vivo daptomycin resistance in enterococci. N. Engl.
J. Med. 365, 892–900. doi: 10.1056/NEJMoa1011138
Arthur, M., Molinas, C., Depardieu, F., and Courvalin, P. (1993). Characterization
of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by
synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium
BM4147. J. Bacteriol. 175, 117–127.
Aslangul, E., Massias, L., Meulemans, A., Chau, F., Andremont, A., Courvalin, P.,
et al. (2006). Acquired gentamicin resistance by permeability impairment
in Enterococcus faecalis. Antimicrob. Agents Chemother. 50, 3615–3621. doi:
10.1128/AAC.00390-06
Bager, F., Madsen, M., Christensen, J., and Aarestrup, F. M. (1997). Avoparcin
used as a growth promoter is associated with the occurrence of vancomycin-
resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med.
31, 95–112. doi: 10.1016/S0167-5877(96)01119-1
Baquero, F. (2004). From pieces to patterns: evolutionary engineering in bacterial
pathogens. Nat. Rev. Microbiol. 2, 510–518. doi: 10.1038/nrmicro909
Barber, K. E., Smith, J. R., Raut, A., and Rybak, M. J. (2016). Evaluation of tedizolid
against Staphylococcus aureus and enterococci with reduced susceptibility to
vancomycin, daptomycin or linezolid. J. Antimicrob. Chemother. 71, 152–155.
doi: 10.1093/jac/dkv302
Barnes, A. M. T., Ballering, K. S., Leibman, R. S., Wells, C. L., and Dunny,
G. M. (2012). Enterococcus faecalis produces abundant extracellular structures
containing DNA in the absence of cell lysis during early biofilm formation. mbio
3:e193. doi: 10.1128/mBio.00193–112
Beabout, K., Hammerstrom, T. G., Perez, A. M., Magalhães, B. F., Prater, A. G.,
Clements, T. P., et al. (2015). The ribosomal S10 protein is a general target
for decreased tigecycline susceptibility. Antimicrob. Agents Chemother. 59,
5561–5566. doi: 10.1128/AAC.00547-15
Bender, J. K., Kalmbach, A., Fleige, C., Klare, I., Fuchs, S., and Werner, G. (2016).
Population structure and acquisition of the vanB resistance determinant in
German clinical isolates of Enterococcus faecium ST192. Sci. Rep. 6:21847. doi:
10.1038/srep21847
Bourdon, N., Fines-Guyon, M., Thiolet, J.-M., Maugat, S., Coignard, B.,
Leclercq, R., et al. (2011). Changing trends in vancomycin-resistant enterococci
in French hospitals, 2001-08. J. Antimicrob. Chemother. 66, 713–721. doi:
10.1093/jac/dkq524
Boyd, D. A., Willey, B. M., Fawcett, D., Gillani, N., and Mulvey, M. R. (2008).
Molecular characterization of Enterococcus faecalis N06-0364 with low-level
vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL.
Antimicrob. Agents Chemother. 52, 2667–2672. doi: 10.1128/AAC.01516-07
Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., et al. (2008).
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune
deficits. Nature 455, 804–807. doi: 10.1038/nature07250
Brodrick, H. J., Raven, K. E., Harrison, E. M., Blane, B., Reuter, S., Török, M. E.,
et al. (2016). Whole-genome sequencing reveals transmission of vancomycin-
resistant Enterococcus faecium in a healthcare network. Genome Med. 8:4. doi:
10.1186/s13073-015-0259-7
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C.,
Schroeder, W., et al. (2005). Dysregulation of bacterial proteolytic machinery
by a new class of antibiotics. Nat. Med. 11, 1082–1087. doi: 10.1038/
nm1306
Byappanahalli, M. N., Nevers, M. B., Korajkic, A., Staley, Z. R., and Harwood, V. J.
(2012). Enterococci in the environment. Microbiol. Mol. Biol. Rev. 76, 685–706.
doi: 10.1128/MMBR.00023-12
Cai, J., Wang, Y., Schwarz, S., Lv, H., Li, Y., Liao, K., et al. (2015). Enterococcal
isolates carrying the novel oxazolidinone resistance gene optrA from hospitals
in Zhejiang, Guangdong, and Henan, China, 2010-2014. Clin. Microbiol.
Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 21, e1–e4. doi:
10.1016/j.cmi.2015.08.007
Cattoir, V., and Giard, J.-C. (2014). Antibiotic resistance in Enterococcus
faecium clinical isolates. Expert Rev. Anti Infect. Ther. 12, 239–248. doi:
10.1586/14787210.2014.870886
Cattoir, V., Isnard, C., Cosquer, T., Odhiambo, A., Bucquet, F., Guérin, F.,
et al. (2015). Genomic analysis of reduced susceptibility to tigecycline
in Enterococcus faecium. Antimicrob. Agents Chemother. 59, 239–244. doi:
10.1128/AAC.04174-14
Chen, C., Sun, J., Guo, Y., Lin, D., Guo, Q., Hu, F., et al. (2015). High
Prevalence of vanM in Vancomycin-Resistant Enterococcus faecium Isolates
from Shanghai, China. Antimicrob. Agents Chemother. 59, 7795–7798. doi:
10.1128/AAC.01732-15
Chen, H., Wu, W., Ni, M., Liu, Y., Zhang, J., Xia, F., et al. (2013). Linezolid-resistant
clinical isolates of enterococci and Staphylococcus cohnii from a multicentre
study in China: molecular epidemiology and resistance mechanisms. Int. J.
Antimicrob. Agents 42, 317–321. doi: 10.1016/j.ijantimicag.2013.06.008
Chow, J. W. (2000). Aminoglycoside resistance in enterococci. Clin. Infect. Dis. Off.
Publ. Infect. Dis. Soc. Am. 31, 586–589. doi: 10.1086/313949
Frontiers in Microbiology | www.frontiersin.org 10 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 11
Guzman Prieto et al. High-risk Enterococcal Clones
Clewell, D. B., Weaver, K. E., Dunny, G. M., Coque, T. M., Francia,
M. V., and Hayes, F. (2014). “Extrachromosomal and mobile elements in
enterococci: transmission, maintenance, and epidemiology,” in Enterococci:
From Commensals to Leading Causes of Drug Resistant Infection, eds M. S.
Gilmore, D. B. Clewell, Y. Ike, and N. Shankar (Boston: Massachusetts Eye and
Ear Infirmary). Available at: http://www.ncbi.nlm.nih.gov/books/NBK190430/
[Accessed March 19, 2016].
Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C.,
Lund, E. T., et al. (2003). Cross-linking in the living cell locates the site
of action of oxazolidinone antibiotics. J. Biol. Chem. 278, 21972–21979. doi:
10.1074/jbc.M302109200
Coombs, G. W., Pearson, J. C., Daley, D. A., Le, T., Robinson, O. J., Gottlieb, T.,
et al. (2014). Molecular epidemiology of enterococcal bacteremia in Australia.
J. Clin. Microbiol. 52, 897–905. doi: 10.1128/JCM.03286-13
Corander, J., Connor, T. R., O’Dwyer, C. A., Kroll, J. S., and Hanage, W. P. (2012).
Population structure in the Neisseria, and the biological significance of fuzzy
species. J. R. Soc. Interface R. Soc. 9, 1208–1215. doi: 10.1098/rsif.2011.0601
Cordina, C., Hill, R., Deshpande, A., Hood, J., and Inkster, T. (2012). Tigecycline-
resistant Enterococcus faecalis associated with omeprazole use in a surgical
patient. J. Antimicrob. Chemother. 67, 1806–1807. doi: 10.1093/jac/dks122
Costa, Y., Galimand, M., Leclercq, R., Duval, J., and Courvalin, P. (1993).
Characterization of the chromosomal aac(6’)-Ii gene specific for
Enterococcus faecium. Antimicrob. Agents Chemother. 37, 1896–1903. doi:
10.1128/AAC.37.9.1896
Courvalin, P. (2006). Vancomycin resistance in gram-positive cocci. Clin. Infect.
Dis. Off. Publ. Infect. Dis. Soc. Am. 42(Suppl. 1), S25–S34. doi: 10.1086/491711
Creti, R., Imperi, M., Bertuccini, L., Fabretti, F., Orefici, G., Di Rosa, R., et al.
(2004). Survey for virulence determinants among Enterococcus faecalis isolated
from different sources. J. Med. Microbiol. 53, 13–20. doi: 10.1099/jmm.0.
05353-0
Crotty, M. P., Krekel, T., Burnham, C. A., and Ritchie, D. J. (2016). New gram-
positive agents: the next generation of oxazolidinones and lipoglycopeptides.
J. Clin. Microbiol. doi: 10.1128/JCM.03395-15 [Epub ahead of print].
Dahl, K. H., Lundblad, E. W., Rokenes, T. P., Olsvik, O., and Sundsfjord, A. (2000).
Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant
enterococci and characterization of two novel insertion sequences. Microbiol.
Read. Engl. 146(Pt 6), 1469–1479. doi: 10.1099/00221287-146-6-1469
Davlieva, M., Zhang, W., Arias, C. A., and Shamoo, Y. (2013). Biochemical
characterization of cardiolipin synthase mutations associated with daptomycin
resistance in enterococci. Antimicrob. Agents Chemother. 57, 289–296. doi:
10.1128/AAC.01743-12
de Been, M., Pinholt, M., Top, J., Bletz, S., Mellmann, A., van Schaik, W.,
et al. (2015). A core genome MLST scheme for high-resolution
typing of Enterococcus faecium. J. Clin. Microbiol. 53, 3788–3797. doi:
10.1128/JCM.01946-15
de Been, M., van Schaik, W., Cheng, L., Corander, J., and Willems, R. J. (2013).
Recent recombination events in the core genome are associated with adaptive
evolution in Enterococcus faecium. Genome Biol. Evol. 5, 1524–1535. doi:
10.1093/gbe/evt111
de Kraker, M. E. A., Jarlier, V., Monen, J. C. M., Heuer, O. E., van de Sande, N., and
Grundmann, H. (2013). The changing epidemiology of bacteraemias in Europe:
trends from the European Antimicrobial Resistance Surveillance System. Clin.
Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 19, 860–868.
doi: 10.1111/1469-0691.12028
De Vecchi, E., Sitia, S., Romanò, C. L., Ricci, C., Mattina, R., and Drago, L.
(2013). Aetiology and antibiotic resistance patterns of urinary tract infections
in the elderly: a 6-month study. J. Med. Microbiol. 62, 859–863. doi:
10.1099/jmm.0.056945-0
Devriese, L. A., Colque, J. I. C., De Herdt, P., and Haesebrouck, F. (1992a).
Identification and composition of the tonsillar and anal enterococcal and
streptococcal flora of dogs and cats. J. Appl. Microbiol. 73, 421–425. doi:
10.1111/j.1365-2672.1992.tb04998.x
Devriese, L. A., Hommez, J., Pot, B., and Haesebrouck, F. (1994). Identification
and composition of the streptococcal and enterococcal flora of tonsils,
intestines and faeces of pigs. J. Appl. Bacteriol. 77, 31–36. doi: 10.1111/j.1365-
2672.1994.tb03040.x
Devriese, L. A., Hommez, J., Wijfels, R., and Haesebrouck, F. (1991). Composition
of the enterococcal and streptococcal intestinal flora of poultry. J. Appl.
Bacteriol. 71, 46–50. doi: 10.1111/j.1365-2672.1991.tb04585.x
Devriese, L. A., Ieven, M., Goossens, H., Vandamme, P., Pot, B., Hommez, J., et al.
(1996). Presence of vancomycin-resistant enterococci in farm and pet animals.
Antimicrob. Agents Chemother. 40, 2285–2287.
Devriese, L. A., Kerckhove, A. V. D., Kilpper-Bälz, R., and Schleifer, K. H. (1987).
Characterization and Identification of Enterococcus Species Isolated from the
Intestines of Animals. Int. J. Syst. Bacteriol. 37, 257–259. doi: 10.1099/00207713-
37-3-257
Devriese, L. A., Laurier, L., De Herdt, P., and Haesebrouck, F. (1992b). Enterococcal
and streptococcal species isolated from faeces of calves, young cattle and
dairy cows. J. Appl. Bacteriol. 72, 29–31. doi: 10.1111/j.1365-2672.1992.
tb05182.x
Diaz, L., Kiratisin, P., Mendes, R. E., Panesso, D., Singh, K. V., and Arias, C. A.
(2012). Transferable plasmid-mediated resistance to linezolid due to cfr in a
human clinical isolate of Enterococcus faecalis. Antimicrob. Agents Chemother.
56, 3917–3922. doi: 10.1128/AAC.00419-12
Didelot, X., and Falush, D. (2007). Inference of bacterial microevolution
using multilocus sequence data. Genetics 175, 1251–1266. doi:
10.1534/genetics.106.063305
Domingo, M.-C., Huletsky, A., Giroux, R., Picard, F. J., and Bergeron, M. G.
(2007). vanD and vanG-Like Gene Clusters in a Ruminococcus Species Isolated
from Human Bowel Flora. Antimicrob. Agents Chemother. 51, 4111–4117. doi:
10.1128/AAC.00584-07
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan,
J. A., Hujer, A. M., et al. (2000). Effect of antibiotic therapy on the
density of vancomycin-resistant enterococci in the stool of colonized
patients. N. Engl. J. Med. 343, 1925–1932. doi: 10.1056/NEJM200012283
432604
Duerkop, B. A., Clements, C. V., Rollins, D., Rodrigues, J. L. M., and Hooper,
L. V. (2012). A composite bacteriophage alters colonization by an intestinal
commensal bacterium. Proc. Natl. Acad. Sci. U.S.A. 109, 17621–17626. doi:
10.1073/pnas.1206136109
Eaton, T. J., and Gasson, M. J. (2001). Molecular screening of Enterococcus
virulence determinants and potential for genetic exchange between
food and medical isolates. Appl. Environ. Microbiol. 67, 1628–1635. doi:
10.1128/AEM.67.4.1628-1635.2001
Edelsberg, J., Weycker, D., Barron, R., Li, X., Wu, H., Oster, G., et al. (2014).
Prevalence of antibiotic resistance in US hospitals. Diagn. Microbiol. Infect. Dis.
78, 255–262. doi: 10.1016/j.diagmicrobio.2013.11.011
Feil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P., and Spratt, B. G. (2004).
eBURST: inferring patterns of evolutionary descent among clusters of related
bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186,
1518–1530. doi: 10.1128/JB.186.5.1518-1530.2004
Fernández-Guerrero, M. L., Herrero, L., Bellver, M., Gadea, I., Roblas, R. F., and de
Górgolas, M. (2002). Nosocomial enterococcal endocarditis: a serious hazard
for hospitalized patients with enterococcal bacteraemia. J. Intern. Med. 252,
510–515. doi: 10.1046/j.1365-2796.2002.01061.x
Fiedler, S., Bender, J. K., Klare, I., Halbedel, S., Grohmann, E., Szewzyk, U.,
et al. (2015). Tigecycline resistance in clinical isolates of Enterococcus
faecium is mediated by an upregulation of plasmid-encoded tetracycline
determinants tet(L) and tet(M). J. Antimicrob. Chemother. 71, 871–881. doi:
10.1093/jac/dkv420
Francisco, A. P., Bugalho, M., Ramirez, M., and Carriço, J. A. (2009). Global
optimal eBURST analysis of multilocus typing data using a graphic matroid
approach. BMC Bioinformatics 10:152. doi: 10.1186/1471-2105-10-152
Freitas, A. R., Novais, C., Correia, R., Monteiro, M., Coque, T. M., and Peixe, L.
(2011). Non-susceptibility to tigecycline in enterococci from hospitalised
patients, food products and community sources. Int. J. Antimicrob. Agents 38,
174–176. doi: 10.1016/j.ijantimicag.2011.04.014
Freitas, A. R., Novais, C., Ruiz-Garbajosa, P., Coque, T. M., and Peixe, L.
(2009). Clonal expansion within clonal complex 2 and spread of vancomycin-
resistant plasmids among different genetic lineages of Enterococcus faecalis
from Portugal. J. Antimicrob. Chemother. 63, 1104–1111. doi: 10.1093/jac/
dkp103
Frontiers in Microbiology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 12
Guzman Prieto et al. High-risk Enterococcal Clones
Furmanek-Blaszk, B., and Sektas, M. (2015). The SfaNI restriction-modification
system from Enterococcus faecalis NEB215 is located on a putative mobile
genetic element. FEMS Microbiol. Lett. 362:fnv028. doi: 10.1093/femsle/fnv028
Gaca, A. O., and Gilmore, M. S. (2016). Killing of VRE Enterococcus faecalis
by commensal strains: evidence for evolution and accumulation of mobile
elements in the absence of competition. Gut Microbes 7, 90–96. doi:
10.1080/19490976.2015.1127482
Galimand, M., Schmitt, E., Panvert, M., Desmolaize, B., Douthwaite, S.,
Mechulam, Y., et al. (2011). Intrinsic resistance to aminoglycosides in
Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific
methyltransferase EfmM. RNA N. Y. N 17, 251–262. doi: 10.1261/rna.2233511
Galloway-Peña, J., Roh, J. H., Latorre, M., Qin, X., and Murray, B. E. (2012).
Genomic and SNP analyses demonstrate a distant separation of the hospital and
community-associated clades of Enterococcus faecium. PLoS ONE 7:e30187. doi:
10.1371/journal.pone.0030187
Galloway-Peña, J. R., Nallapareddy, S. R., Arias, C. A., Eliopoulos, G. M., and
Murray, B. E. (2009). Analysis of clonality and antibiotic resistance among early
clinical isolates of Enterococcus faecium in the United States. J. Infect. Dis. 200,
1566–1573. doi: 10.1086/644790
Galloway-Peña, J. R., Rice, L. B., and Murray, B. E. (2011). Analysis of PBP5 of early
U.S. isolates of Enterococcus faecium: sequence variation alone does not explain
increasing ampicillin resistance over time. Antimicrob. Agents Chemother. 55,
3272–3277. doi: 10.1128/AAC.00099-11
Gastmeier, P., Schröder, C., Behnke, M., Meyer, E., and Geffers, C. (2014). Dramatic
increase in vancomycin-resistant enterococci in Germany. J. Antimicrob.
Chemother. 69, 1660–1664. doi: 10.1093/jac/dku035
Gilmore, M. S., Lebreton, F., and van Schaik, W. (2013). Genomic transition
of enterococci from gut commensals to leading causes of multidrug-resistant
hospital infection in the antibiotic era. Curr. Opin. Microbiol. 16, 10–16. doi:
10.1016/j.mib.2013.01.006
Grayson, M. L., Eliopoulos, G. M., Wennersten, C. B., Ruoff, K. L., De
Girolami, P. C., Ferraro, M. J., et al. (1991). Increasing resistance to beta-
lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year
review at one institution. Antimicrob. Agents Chemother. 35, 2180–2184. doi:
10.1128/AAC.35.11.2180
Guardabassi, L., Perichon, B., van Heijenoort, J., Blanot, D., and Courvalin, P.
(2005). Glycopeptide resistance vana operons in paenibacillus strains
isolated from soil. Antimicrob. Agents Chemother. 49, 4227–4233. doi:
10.1128/AAC.49.10.4227-4233.2005
Hanrahan, J., Hoyen, C., and Rice, L. B. (2000). Geographic distribution of a large
mobile element that transfers ampicillin and vancomycin resistance between
Enterococcus faecium strains. Antimicrob. Agents Chemother. 44, 1349–1351.
doi: 10.1128/AAC.44.5.1349-1351.2000
Hegstad, K., Mikalsen, T., Coque, T. M., Werner, G., and Sundsfjord, A.
(2010). Mobile genetic elements and their contribution to the emergence of
antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin.
Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 16, 541–554.
doi: 10.1111/j.1469-0691.2010.03226.x
Heikens, E., Bonten, M. J., and Willems, R. J. (2007). Enterococcal Surface
Protein Esp Is Important for Biofilm Formation of Enterococcus faecium E1162.
J. Bacteriol. 189, 8233–8240. doi: 10.1128/JB.01205-07
Heikens, E., Singh, K. V., Jacques-Palaz, K. D., van Luit-Asbroek, M., Oostdijk,
E. A. N., Bonten, M. J. M., et al. (2011). Contribution of the enterococcal
surface protein Esp to pathogenesis of Enterococcus faecium endocarditis.
Microbes Infect. Inst. Pasteur 13, 1185–1190. doi: 10.1016/j.micinf.2011.
08.006
Heikens, E., van Schaik, W., Leavis, H. L., Bonten, M. J., and Willems, R. J.
(2008). Identification of a novel genomic island specific to hospital-acquired
clonal complex 17 Enterococcus faecium isolates. Appl. Environ. Microbiol. 74,
7094–7097. doi: 10.1128/AEM.01378-08
Hendrickx, A. P., Willems, R. J., Bonten, M. J., and van Schaik, W. (2009).
LPxTG surface proteins of enterococci. Trends Microbiol. 17, 423–430. doi:
10.1016/j.tim.2009.06.004
Hendrickx, A. P. A., van Schaik, W., and Willems, R. J. L. (2013). The cell wall
architecture of Enterococcus faecium: from resistance to pathogenesis. Fut.
Microbiol. 8, 993–1010. doi: 10.2217/fmb.13.66
Hoban, D. J., Reinert, R. R., Bouchillon, S. K., and Dowzicky, M. J. (2015). Global
in vitro activity of tigecycline and comparator agents: tigecycline Evaluation
and Surveillance Trial 2004-2013. Ann. Clin. Microbiol. Antimicrob. 14:27. doi:
10.1186/s12941-015-0085-1
Homan, W. L., Tribe, D., Poznanski, S., Li, M., Hogg, G., Spalburg, E., et al. (2002).
Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol.
40, 1963–1971. doi: 10.1128/JCM.40.6.1963-1971.2002
Horvath, P., and Barrangou, R. (2010). CRISPR/Cas, the immune system of
bacteria and archaea. Science 327, 167–170. doi: 10.1126/science.1179555
Howden, B. P., Holt, K. E., Lam, M. M. C., Seemann, T., Ballard, S., Coombs,
G. W., et al. (2013). Genomic insights to control the emergence of vancomycin-
resistant enterococci. mBio 4, e412–e413. doi: 10.1128/mBio.00412-13
Humphries, R. M., Pollett, S., and Sakoulas, G. (2013). A current perspective on
daptomycin for the clinical microbiologist. Clin. Microbiol. Rev. 26, 759–780.
doi: 10.1128/CMR.00030-13
Jensen, L. B., Ahrens, P., Dons, L., Jones, R. N., Hammerum, A. M., and Aarestrup,
F. M. (1998). Molecular analysis of Tn1546 in Enterococcus faecium isolated
from animals and humans. J. Clin. Microbiol. 36, 437–442.
Jones, R. N., Ross, J. E., Castanheira, M., and Mendes, R. E. (2008). United
States resistance surveillance results for linezolid (LEADER Program for 2007).
Diagn. Microbiol. Infect. Dis. 62, 416–426. doi: 10.1016/j.diagmicrobio.2008.
10.010
Jones, R. N., Sader, H. S., and Flamm, R. K. (2013). Update of dalbavancin
spectrum and potency in the USA: report from the SENTRY Antimicrobial
Surveillance Program (2011). Diagn. Microbiol. Infect. Dis. 75, 304–307. doi:
10.1016/j.diagmicrobio.2012.11.024
Jordan, S., Junker, A., Helmann, J. D., and Mascher, T. (2006). Regulation
of LiaRS-dependent gene expression in Bacillus subtilis: identification of
inhibitor proteins, regulator binding sites, and target genes of a conserved cell
envelope stress-sensing two-component system. J. Bacteriol. 188, 5153–5166.
doi: 10.1128/JB.00310-06
Kamboj, M., Blair, R., Bell, N., Sun, J., Eagan, J., and Sepkowitz, K. (2014). What is
the source of bloodstream infection due to vancomycin-resistant enterococci
in persons with mucosal barrier injury? Infect. Control Hosp. Epidemiol. 35,
99–101. doi: 10.1086/674406
Karlowsky, J. A., Nichol, K., and Zhanel, G. G. (2015). Telavancin: mechanisms
of action, in vitro activity, and mechanisms of resistance. Clin. Infect. Dis. Off.
Publ. Infect. Dis. Soc. Am. 61(Suppl. 2), S58–S68. doi: 10.1093/cid/civ534
Kawalec, M., Pietras, Z., Daniłowicz, E., Jakubczak, A., Gniadkowski, M.,
Hryniewicz, W., et al. (2007). Clonal structure of Enterococcus faecalis isolated
from Polish hospitals: characterization of epidemic clones. J. Clin. Microbiol. 45,
147–153. doi: 10.1128/JCM.01704-06
Kelesidis, T., Tewhey, R., and Humphries, R. M. (2013). Evolution of high-level
daptomycin resistance in Enterococcus faecium during daptomycin therapy
is associated with limited mutations in the bacterial genome. J. Antimicrob.
Chemother. 68, 1926–1928. doi: 10.1093/jac/dkt117
Kim, E. B., and Marco, M. L. (2013). Non-clinical and clinical Enterococcus faecium
but not Enterococcus faecalis have distinct structural and functional genomic
features. Appl. Environ. Microbiol. 80, 154–165.
Klare, I., Badstübner, D., Konstabel, C., Böhme, G., Claus, H., and Witte, W. (1999).
Decreased incidence of VanA-type vancomycin-resistant enterococci isolated
from poultry meat and from fecal samples of humans in the community after
discontinuation of avoparcin usage in animal husbandry. Microb. Drug Resist.
Larchmt. N 5, 45–52. doi: 10.1089/mdr.1999.5.45
Klare, I., Heier, H., Claus, H., Böhme, G., Marin, S., Seltmann, G., et al. (1995).
Enterococcus faecium strains with vanA-mediated high-level glycopeptide
resistance isolated from animal foodstuffs and fecal samples of humans
in the community. Microb. Drug Resist. Larchmt. N 1, 265–272. doi:
10.1089/mdr.1995.1.265
Kuch, A., Willems, R. J. L., Werner, G., Coque, T. M., Hammerum, A. M.,
Sundsfjord, A., et al. (2012). Insight into antimicrobial susceptibility and
population structure of contemporary human Enterococcus faecalis isolates
from Europe. J. Antimicrob. Chemother. 67, 551–558. doi: 10.1093/jac/
dkr544
La Rosa, S. L., Montealegre, M. C., Singh, K. V., and Murray, B. E.
(2016). Enterococcus faecalis Ebp Pili are important for cell-cell aggregation
and intraspecies gene transfer. Microbiol. Read. Engl. 162, 798–802. doi:
10.1099/mic.0.000276
La Rosa, S. L., Snipen, L.-G., Murray, B. E., Willems, R. J. L., Gilmore, M. S., Diep,
D. B., et al. (2015). A genomic virulence reference map of Enterococcus faecalis
Frontiers in Microbiology | www.frontiersin.org 12 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 13
Guzman Prieto et al. High-risk Enterococcal Clones
reveals an important contribution of phage03-like elements in nosocomial
genetic lineages to pathogenicity in a Caenorhabditis elegans infection model.
Infect. Immun. 83, 2156–2167. doi: 10.1128/IAI.02801-14
Leavis, H., Top, J., Shankar, N., Borgen, K., Bonten, M., Van Embden, J.,
et al. (2004). a novel putative enterococcal pathogenicity island linked
to the esp virulence gene of Enterococcus faecium and associated
with epidemicity. J. Bacteriol. 186, 672–682. doi: 10.1128/JB.186.3.672-
682.2004
Leavis, H. L., Willems, R. J., Top, J., Spalburg, E., Mascini, E. M., Fluit, A. C., et al.
(2003). Epidemic and nonepidemic multidrug-resistant Enterococcus faecium.
Emerg. Infect. Dis. 9, 1108–1115. doi: 10.3201/eid0909.020383
Lebreton, F., Depardieu, F., Bourdon, N., Fines-Guyon, M., Berger, P., Camiade, S.,
et al. (2011). D-Ala-d-Ser VanN-type transferable vancomycin resistance in
Enterococcus faecium. Antimicrob. Agents Chemother. 55, 4606–4612. doi:
10.1128/AAC.00714-11
Lebreton, F., van Schaik, W., McGuire, A. M., Godfrey, P., Griggs, A.,
Mazumdar, V., et al. (2013). Emergence of epidemic multidrug-resistant
Enterococcus faecium from animal and commensal strains. mBio 4:e534. doi:
10.1128/mBio.00534-13
Leclercq, R., Derlot, E., Duval, J., and Courvalin, P. (1988). Plasmid-
mediated resistance to vancomycin and teicoplanin in Enterococcus
faecium. N. Engl. J. Med. 319, 157–161. doi: 10.1056/NEJM1988072131
90307
Leclercq, R., Oberlé, K., Galopin, S., Cattoir, V., Budzinski, H., and Petit, F.
(2013). Changes in enterococcal populations and related antibiotic
resistance along a medical center-wastewater treatment plant-river
continuum. Appl. Environ. Microbiol. 79, 2428–2434. doi: 10.1128/AEM.
03586-12
Leendertse, M., Heikens, E., Wijnands, L. M., van Luit-Asbroek, M., Teske, G. J.,
Roelofs, J. J., et al. (2009). Enterococcal surface protein transiently aggravates
Enterococcus faecium-induced urinary tract infection in mice. J. Infect. Dis. 200,
1162–1165. doi: 10.1086/605609
Lellek, H., Franke, G. C., Ruckert, C., Wolters, M., Wolschke, C.,
Christner, M., et al. (2015). Emergence of daptomycin non-susceptibility
in colonizing vancomycin-resistant Enterococcus faecium isolates during
daptomycin therapy. Int. J. Med. Microbiol. IJMM 305, 902–909. doi:
10.1016/j.ijmm.2015.09.005
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I.,
Conlon, B. P., et al. (2015). A new antibiotic kills pathogens without
detectable resistance. Nature 517, 455–459. doi: 10.1038/nature
14098
Lübbert, C., Rodloff, A. C., and Hamed, K. (2015). Real-world treatment of
enterococcal infections with daptomycin: insights from a large european
registry (EU-CORE). Infect. Dis. Ther. 4, 259–271. doi: 10.1007/s40121-015-
0072-z
Manson, J. M., Hancock, L. E., and Gilmore, M. S. (2010). Mechanism of
chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule,
antimicrobial resistance, and other traits. Proc. Natl. Acad. Sci. U.S.A. 107,
12269–12274. doi: 10.1073/pnas.1000139107
Martin, J. D., and Mundt, J. O. (1972). Enterococci in insects. Appl. Microbiol. 24,
575–580.
Matos, R. C., Lapaque, N., Rigottier-Gois, L., Debarbieux, L., Meylheuc, T.,
Gonzalez-Zorn, B., et al. (2013). Enterococcus faecalis prophage dynamics
and contributions to pathogenic traits. PLoS Genet. 9:e1003539. doi:
10.1371/journal.pgen.1003539
McBride, S. M., Fischetti, V. A., Leblanc, D. J., Moellering, R. C. Jr., and Gilmore,
M. S. (2007). Genetic diversity among Enterococcus faecalis. PLoS ONE 2:e582.
doi: 10.1371/journal.pone.0000582
Miller, W. R., Munita, J. M., and Arias, C. A. (2014). Mechanisms of antibiotic
resistance in enterococci. Expert Rev. Anti Infect. Ther. 12, 1221–1236. doi:
10.1586/14787210.2014.956092
Montealegre, M. C., Singh, K. V., and Murray, B. E. (2015). Gastrointestinal tract
colonization dynamics by different Enterococcus faecium clades. J. Infect. Dis.
doi: 10.1093/infdis/jiv597 [Epub ahead of print].
Montero, C. I., Stock, F., and Murray, P. R. (2008). Mechanisms of resistance
to daptomycin in Enterococcus faecium. Antimicrob. Agents Chemother. 52,
1167–1170. doi: 10.1128/AAC.00774-07
Morris, J. J., Lenski, R. E., and Zinser, E. R. (2012). The Black Queen Hypothesis:
evolution of dependencies through adaptive gene loss. mBio 3:e00036. doi:
10.1128/mBio.00036-12
Morrison, D., Woodford, N., Barrett, S. P., Sisson, P., and Cookson, B. D. (1999).
DNA banding pattern polymorphism in vancomycin-resistant Enterococcus
faecium and criteria for defining strains. J. Clin. Microbiol. 37, 1084–1091.
Mundt, J. O. (1963a). Occurrence of enterococci in animals in a wild environment.
Appl. Microbiol. 11, 136–140.
Mundt, J. O. (1963b). Occurrence of enterococci on plants in a wild environment.
Appl. Microbiol. 11, 141–144.
Munita, J. M., Mishra, N. N., Alvarez, D., Tran, T. T., Diaz, L., Panesso, D., et al.
(2014). Failure of high-dose daptomycin for bacteremia caused by daptomycin-
susceptible Enterococcus faecium harboring LiaSR substitutions. Clin. Infect.
Dis. Off. Publ. Infect. Dis. Soc. Am. 59, 1277–1280. doi: 10.1093/cid/ciu642
Munita, J. M., Panesso, D., Diaz, L., Tran, T. T., Reyes, J., Wanger, A., et al.
(2012). Correlation between Mutations in liaFSR of Enterococcus faecium and
MIC of daptomycin: revisiting daptomycin breakpoints. Antimicrob. Agents
Chemother. 56, 4354–4359. doi: 10.1128/AAC.00509-12
National Nosocomial Infections Surveillance System (2004). National Nosocomial
Infections Surveillance (NNIS) System Report, data summary from January
1992 through June 2004, issued October 2004. Am. J. Infect. Control 32,
470–485. doi: 10.1016/S0196655304005425
Neelakanta, A., Sharma, S., Kesani, V. P., Salim, M., Pervaiz, A., Aftab, N.,
et al. (2015). Impact of changes in the NHSN catheter-associated urinary tract
infection (CAUTI) surveillance criteria on the frequency and epidemiology
of CAUTI in intensive care units (ICUs). Infect. Control Hosp. Epidemiol. 36,
346–349. doi: 10.1017/ice.2014.67
Niebel, M., Quick, J., Prieto, A. M. G., Hill, R. L. R., Pike, R., Huber, D., et al. (2015).
Deletions in a ribosomal protein-coding gene are associated with tigecycline
resistance in Enterococcus faecium. Int. J. Antimicrob. Agents 46, 572–575. doi:
10.1016/j.ijantimicag.2015.07.009
Numminen, E., Gutmann, M., Shubin, M., Marttinen, P., Méric, G., van
Schaik, W., et al. (2016). The impact of host metapopulation structure on
the population genetics of colonizing bacteria. J. Theor. Biol. 396, 53–62. doi:
10.1016/j.jtbi.2016.02.019
Paganelli, F. L., Huebner, J., Singh, K. V., Zhang, X., van Schaik, W., Wobser, D.,
et al. (2016). Genome-wide screening identifies PTS permease BepA to be
involved in Enterococcus faecium endocarditis and biofilm formation. J. Infect.
Dis. doi: 10.1093/infdis/jiw108 [Epub ahead of print].
Paganelli, F. L., Willems, R. J. L., Jansen, P., Hendrickx, A., Zhang, X.,
Bonten, M. J. M., et al. (2013). Enterococcus faecium biofilm formation:
identification of major autolysin AtlAEfm, associated Acm surface localization,
and atlaefm-independent extracellular DNA release. mBio 4:e154. doi:
10.1128/mBio.00154-13
Palmer, K. L., Daniel, A., Hardy, C., Silverman, J., and Gilmore, M. S. (2011).
Genetic basis for daptomycin resistance in enterococci. Antimicrob. Agents
Chemother. 55, 3345–3356. doi: 10.1128/AAC.00207-11
Palmer, K. L., Godfrey, P., Griggs, A., Kos, V. N., Zucker, J., Desjardins, C., et al.
(2012). Comparative genomics of enterococci: variation in Enterococcus faecalis,
clade structure in E. faecium, and defining characteristics of E. gallinarum and
E. casseliflavus. mBio 3:e318. doi: 10.1128/mBio.00318-11
Palmer, K. L., Kos, V. N., and Gilmore, M. S. (2010). Horizontal gene transfer and
the genomics of enterococcal antibiotic resistance. Curr. Opin. Microbiol. 13,
632–639. doi: 10.1016/j.mib.2010.08.004
Parte, A. C. (2014). LPSN–list of prokaryotic names with standing in nomenclature.
Nucleic Acids Res. 42, D613–D616. doi: 10.1093/nar/gkt1111
Patterson, J. E., Sweeney, A. H., Simms, M., Carley, N., Mangi, R., Sabetta, J.,
et al. (1995). An analysis of 110 serious enterococcal infections. Epidemiology,
antibiotic susceptibility, and outcome. Medicine (Baltimore) 74, 191–200. doi:
10.1097/00005792-199507000-00003
Pinholt, M., Larner-Svensson, H., Littauer, P., Moser, C. E., Pedersen, M.,
Lemming, L. E., et al. (2015). Multiple hospital outbreaks of vanA Enterococcus
faecium in Denmark, 2012–13, investigated by WGS, MLST and PFGE.
J. Antimicrob. Chemother. 70, 2474–2482. doi: 10.1093/jac/dkv142
Polidori, M., Nuccorini, A., Tascini, C., Gemignani, G., Iapoce, R.,
Leonildi, A., et al. (2011). Vancomycin-resistant Enterococcus faecium (VRE)
bacteremia in infective endocarditis successfully treated with combination
Frontiers in Microbiology | www.frontiersin.org 13 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 14
Guzman Prieto et al. High-risk Enterococcal Clones
daptomycin and tigecycline. J. Chemother. Florence Italy 23, 240–241. doi:
10.1179/joc.2011.23.4.240
Raven, K. E., Reuter, S., Gouliouris, T., Reynolds, R., Russell, J. E., Brown, N. M.,
et al. (2016). Genome-based characterization of hospital-adapted Enterococcus
faecalis lineages. Nat. Microbiol. 15033. doi: 10.1038/nmicrobiol.2015.33
Reuter, S., Ellington, M. J., Cartwright, E. J. P., Köser, C. U., Török, M. E.,
Gouliouris, T., et al. (2013). Rapid bacterial whole-genome sequencing to
enhance diagnostic and public health microbiology. JAMA Intern. Med. 173,
1397–1404. doi: 10.1001/jamainternmed.2013.7734
Rice, L. B., Carias, L. L., Hutton-Thomas, R., Sifaoui, F., Gutmann, L., and Rudin,
S. D. (2001). Penicillin-binding protein 5 and expression of ampicillin resistance
in Enterococcus faecium. Antimicrob. Agents Chemother. 45, 1480–1486. doi:
10.1128/AAC.45.5.1480-1486.2001
Rice, L. B., Carias, L. L., Rudin, S., Lakticová, V., Wood, A., and Hutton-Thomas, R.
(2005). Enterococcus faecium low-affinity pbp5 is a transferable determinant.
Antimicrob. Agents Chemother. 49, 5007–5012. doi: 10.1128/AAC.49.12.5007-
5012.2005
Ruiz-Garbajosa, P., Bonten, M. J. M., Robinson, D. A., Top, J., Nallapareddy,
S. R., Torres, C., et al. (2006). Multilocus sequence typing scheme
for Enterococcus faecalis reveals hospital-adapted genetic complexes in a
background of high rates of recombination. J. Clin. Microbiol. 44, 2220–2228.
doi: 10.1128/JCM.02596-05
Ruiz-Garbajosa, P., de Regt, M., Bonten, M., Baquero, F., Coque, T. M.,
Cantón, R., et al. (2012). High-density fecal Enterococcus faecium colonization
in hospitalized patients is associated with the presence of the polyclonal
subcluster CC17. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin.
Microbiol. 31, 519–522. doi: 10.1007/s10096-011-1342-7
Ruiz-Garbajosa, P., del Campo, R., Coque, T. M., Asensio, A., Bonten, M.,
Willems, R., et al. (2009). Longer intestinal persistence of Enterococcus faecalis
compared to Enterococcus faecium clones in intensive-care-unit patients. J. Clin.
Microbiol. 47, 345–351. doi: 10.1128/JCM.01597-08
Sader, H. S., Farrell, D. J., Flamm, R. K., and Jones, R. N. (2014). Daptomycin
activity tested against 164457 bacterial isolates from hospitalised patients:
summary of 8 years of a Worldwide Surveillance Programme (2005-2012). Int.
J. Antimicrob. Agents 43, 465–469. doi: 10.1016/j.ijantimicag.2014.01.018
Salipante, S. J., SenGupta, D. J., Cummings, L. A., Land, T. A., Hoogestraat,
D. R., and Cookson, B. T. (2015). Application of whole-genome sequencing
for bacterial strain typing in molecular epidemiology. J. Clin. Microbiol. 53,
1072–1079. doi: 10.1128/JCM.03385-14
Sarti, M., Campanile, F., Sabia, C., Santagati, M., Gargiulo, R., and Stefani, S. (2012).
Polyclonal diffusion of beta-lactamase-producing Enterococcus faecium. J. Clin.
Microbiol. 50, 169–172. doi: 10.1128/JCM.05640-11
Sava, I. G., Heikens, E., Kropec, A., Theilacker, C., Willems, R., and Huebner, J.
(2010). Enterococcal surface protein contributes to persistence in the host but
is not a target of opsonic and protective antibodies in Enterococcus faecium
infection. J. Med. Microbiol. 59, 1001–1004. doi: 10.1099/jmm.0.020578-0
Scheetz, M. H., Knechtel, S. A., Malczynski, M., Postelnick, M. J., and
Qi, C. (2008). Increasing incidence of linezolid-intermediate or -resistant,
vancomycin-resistant Enterococcus faecium strains parallels increasing
linezolid consumption. Antimicrob. Agents Chemother. 52, 2256–2259. doi:
10.1128/AAC.00070-08
Shen, J., Wang, Y., and Schwarz, S. (2013). Presence and dissemination of
the multiresistance gene cfr in Gram-positive and Gram-negative bacteria.
J. Antimicrob. Chemother. 68, 1697–1706. doi: 10.1093/jac/dkt092
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A.,
et al. (2013). Antimicrobial-resistant pathogens associated with healthcare-
associated infections: summary of data reported to the National Healthcare
Safety Network at the Centers for Disease Control and Prevention,
2009–2010. Infect. Control Hosp. Epidemiol. 34, 1–14. doi: 10.1086/
668770
Silva-Del Toro, S. L., Greenwood-Quaintance, K. E., and Patel, R. (2016).
In vitro activity of tedizolid against linezolid-resistant staphylococci
and enterococci. Diagn. Microbiol. Infect. Dis. 85, 102–104. doi:
10.1016/j.diagmicrobio.2016.02.008
Simner, P. J., Adam, H., Baxter, M., McCracken, M., Golding, G., Karlowsky, J. A.,
et al. (2015). Epidemiology of vancomycin-resistant enterococci in Canadian
hospitals (CANWARD study, 2007 to 2013). Antimicrob. Agents Chemother. 59,
4315–4317. doi: 10.1128/AAC.00384-15
Solheim, M., Aakra, A., Snipen, L. G., Brede, D. A., and Nes, I. F. (2009).
Comparative genomics of Enterococcus faecalis from healthy Norwegian
infants. BMC Genomics 10:194. doi: 10.1186/1471-2164-10-194
Stobberingh, E., Van Den Bogaard, A., London, N., Driessen, C., Top, J., and
Willems, R. (1999). Enterococci with glycopeptide resistance in turkeys, turkey
farmers, turkey slaughterers, and (sub)urban residents in the south of The
Netherlands: evidence for transmission of vancomycin resistance from animals
to humans? Antimicrob. Agents Chemother. 43, 2215–2221.
Sydnor, E. R. M., and Perl, T. M. (2011). Hospital epidemiology and infection
control in acute-care settings. Clin. Microbiol. Rev. 24, 141–173. doi:
10.1128/CMR.00027-10
Tannock, G. W., and Cook, G. (2002). “Enterococci as members of the Intestinal
microflora of humans,” in The Enterococci: Pathogenesis, Molecular Biology,
and Antibiotic Resistance, ed. M. S. Gilmore (Washington, DC: ASM Press),
101–132.
Tedim, A. P., Ruiz-Garbajosa, P., Corander, J., Rodríguez, C. M., Cantón, R.,
Willems, R. J., et al. (2015). Population biology of intestinal Enterococcus
isolates from hospitalized and nonhospitalized individuals in different
age groups. Appl. Environ. Microbiol. 81, 1820–1831. doi: 10.1128/AEM.
03661-14
Thomas, J. C., Zhang, L., and Robinson, D. A. (2014). Differing lifestyles
of Staphylococcus epidermidis as revealed through Bayesian clustering of
multilocus sequence types. Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet.
Infect. Dis. 22, 257–264. doi: 10.1016/j.meegid.2013.06.020
Tomayko, J. F., Zscheck, K. K., Singh, K. V., and Murray, B. E. (1996). Comparison
of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus
faecalis. Antimicrob. Agents Chemother. 40, 1170–1174.
Top, J., Sinnige, J. C., Majoor, E. A., Bonten, M. J., Willems, R. J., and van
Schaik, W. (2011). The Recombinase IntA is required for excision of esp-
containing ICEEfm1 in Enterococcus faecium. J. Bacteriol. 193, 1003–1006. doi:
10.1128/JB.00952-10
Top, J., Willems, R., and Bonten, M. (2008). Emergence of CC17 Enterococcus
faecium: from commensal to hospital-adapted pathogen. FEMS Immunol. Med.
Microbiol. 52, 297–308. doi: 10.1111/j.1574-695X.2008.00383.x
Tran, T. T., Panesso, D., Gao, H., Roh, J. H., Munita, J. M., Reyes, J., et al. (2013a).
Whole-genome analysis of a daptomycin-susceptible Enterococcus faecium
strain and its daptomycin-resistant variant arising during therapy. Antimicrob.
Agents Chemother. 57, 261–268. doi: 10.1128/AAC.01454-12
Tran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M.,
et al. (2013b). Daptomycin-resistant Enterococcus faecalis diverts the antibiotic
molecule from the division septum and remodels cell membrane phospholipids.
mBio 4:e00281. doi: 10.1128/mBio.00281-13
Turner, K. M. E., Hanage, W. P., Fraser, C., Connor, T. R., and Spratt, B. G. (2007).
Assessing the reliability of eBURST using simulated populations with known
ancestry. BMC Microbiol. 7:30. doi: 10.1186/1471-2180-7-30
Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., et al. (2010).
Vancomycin-resistant Enterococcus domination of intestinal microbiota is
enabled by antibiotic treatment in mice and precedes bloodstream invasion in
humans. J. Clin. Invest. 120, 4332–4341. doi: 10.1172/JCI43918
Uttley, A. H., Collins, C. H., Naidoo, J., and George, R. C. (1988). Vancomycin-
resistant enterococci. Lancet Lond. Engl. 332, 57–58. doi: 10.1016/S0140-
6736(88)91037-9
van den Bogaard, A. E., Bruinsma, N., and Stobberingh, E. E. (2000). The effect
of banning avoparcin on VRE carriage in The Netherlands. J. Antimicrob.
Chemother. 46, 146–148. doi: 10.1093/jac/46.1.146
van Hal, S. J., Ip, C. L. C., Ansari, M. A., Wilson, D. J., Espedido, B. A., Jensen,
S. O., et al. (2016). Evolutionary dynamics of Enterococcus faecium reveals
complex genomic relationships between isolates with independent emergence
of vancomycin resistance. Microb. Genomics 2:48. doi: 10.1099/mgen.0.
000048
van Schaik, W., Top, J., Riley, D. R., Boekhorst, J., Vrijenhoek, J. E., Schapendonk,
C. M., et al. (2010). Pyrosequencing-based comparative genome analysis of
the nosocomial pathogen Enterococcus faecium and identification of a large
transferable pathogenicity island. BMC Genomics 11:239. doi: 10.1186/1471-
2164-11-239
Van Tyne, D., and Gilmore, M. S. (2014). Friend turned foe: evolution of
enterococcal virulence and antibiotic resistance. Annu. Rev. Microbiol. 68,
337–356. doi: 10.1146/annurev-micro-091213-113003
Frontiers in Microbiology | www.frontiersin.org 14 May 2016 | Volume 7 | Article 788
fmicb-07-00788 May 24, 2016 Time: 12:30 # 15
Guzman Prieto et al. High-risk Enterococcal Clones
Via, S. (2012). Divergence hitchhiking and the spread of genomic isolation during
ecological speciation-with-gene-flow. Philos. Trans. R. Soc. Lond. B. Biol. Sci.
367, 451–460. doi: 10.1098/rstb.2011.0260
Wang, Y., Lv, Y., Cai, J., Schwarz, S., Cui, L., Hu, Z., et al. (2015). A novel
gene, optrA, that confers transferable resistance to oxazolidinones and
phenicols and its presence in Enterococcus faecalis and Enterococcus faecium
of human and animal origin. J. Antimicrob. Chemother. 70, 2182–2190. doi:
10.1093/jac/dkv116
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K.,
et al. (2007). High-level vancomycin-resistant Staphylococcus aureus isolates
associated with a polymicrobial biofilm. Antimicrob. Agents Chemother. 51,
231–238. doi: 10.1128/AAC.00576-06
Werner, G., Coque, T. M., Franz, C. M. A. P., Grohmann, E., Hegstad, K.,
Jensen, L., et al. (2013). Antibiotic resistant enterococci-tales of a drug
resistance gene trafficker. Int. J. Med. Microbiol. IJMM 303, 360–379. doi:
10.1016/j.ijmm.2013.03.001
Werner, G., Gfrörer, S., Fleige, C., Witte, W., and Klare, I. (2008). Tigecycline-
resistant Enterococcus faecalis strain isolated from a German intensive care unit
patient. J. Antimicrob. Chemother. 61, 1182–1183. doi: 10.1093/jac/dkn065
Willems, R. J., Homan, W., Top, J., van Santen-Verheuvel, M., Tribe, D.,
Manzioros, X., et al. (2001). Variant esp gene as a marker of a distinct genetic
lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals.
Lancet 357, 853–855. doi: 10.1016/S0140-6736(00)04205-7
Willems, R. J., Top, J., van Den Braak, N., van Belkum, A., Endtz, H., Mevius, D.,
et al. (2000). Host specificity of vancomycin-resistant Enterococcus faecium.
J. Infect. Dis. 182, 816–823. doi: 10.1086/315752
Willems, R. J., Top, J., van den Braak, N., van Belkum, A., Mevius, D. J.,
Hendriks, G., et al. (1999). Molecular diversity and evolutionary relationships
of Tn1546-like elements in enterococci from humans and animals. Antimicrob.
Agents Chemother. 43, 483–491.
Willems, R. J., Top, J., van Santen, M., Robinson, D. A., Coque, T. M., Baquero, F.,
et al. (2005). Global spread of vancomycin-resistant Enterococcus faecium from
distinct nosocomial genetic complex. Emerg. Infect. Dis. 11, 821–828. doi:
10.3201/1106.041204
Willems, R. J. L., Top, J., van Schaik, W., Leavis, H., Bonten, M., Sirén, J., et al.
(2012). Restricted gene flow among hospital subpopulations of Enterococcus
faecium. mBio 3:e151. doi: 10.1128/mBio.00151-12
Woodford, N., Adebiyi, A. M., Palepou, M. F., and Cookson, B. D. (1998). Diversity
of VanA glycopeptide resistance elements in enterococci from humans and
nonhuman sources. Antimicrob. Agents Chemother. 42, 502–508.
Xu, X., Lin, D., Yan, G., Ye, X., Wu, S., Guo, Y., et al. (2010). vanM, a new
glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob.
Agents Chemother. 54, 4643–4647. doi: 10.1128/AAC.01710-09
Zhang, X., Paganelli, F. L., Bierschenk, D., Kuipers, A., Bonten, M. J. M.,
Willems, R. J. L., et al. (2012). Genome-wide identification of ampicillin
resistance determinants in Enterococcus faecium. PLoS Genet. 8:e1002804. doi:
10.1371/journal.pgen.1002804
Zhang, X., Top, J., de Been, M., Bierschenk, D., Rogers, M., Leendertse, M., et al.
(2013). Identification of a genetic determinant in clinical Enterococcus
faecium strains that contributes to intestinal colonization during
antibiotic treatment. J. Infect. Dis. 207, 1780–1786. doi: 10.1093/infdis/
jit076
Zorzi, W., Zhou, X. Y., Dardenne, O., Lamotte, J., Raze, D., Pierre, J., et al. (1996).
Structure of the low-affinity penicillin-binding protein 5 PBP5fm in wild-type
and highly penicillin-resistant strains of Enterococcus faecium. J. Bacteriol. 178,
4948–4957.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Guzman Prieto, van Schaik, Rogers, Coque, Baquero, Corander
and Willems. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) or licensor are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 15 May 2016 | Volume 7 | Article 788
